Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Gottlieb's Confirmation: Will Industry Ties Remain A Problem After The Hearing?

Apr 04 2017

• By Derrick Gingery

Related Content

Woodcock Tries To Calm US FDA Staff Fears About Trump

Dec 21 2016

Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process

Mar 13 2017

HHS Overrules FDA On Plan B OTC, Sends Teva Back To Drawing Board

Dec 07 2011

Califf Has Several Industry Ties To Sever Before Joining FDA

Feb 02 2015

Sarepta's Eteplirsen Approved After Contentious Internal FDA Debate

Sep 20 2016

FDA Nominee Gottlieb's Recusals Span Clinical Decision Software Firms, Imaging Centers, Drug Makers

Apr 04 2017

Political Appointees Shouldn't Influence Approval Decisions, Califf Says

Oct 20 2016

Related Companies

GSK plc

Molecular Insight Pharmaceuticals, Inc.

Teva Pharmaceutical Industries Ltd.

Sarepta Therapeutics, Inc.

Additional Topics

United States FDA Regulation Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window